In a significant victory for pharmaceutical competition and access to generic drugs, Jenner & Block secured a key litigation win on behalf of client MSN Pharmaceuticals. A federal judge denied a pharmaceutical company’s...more
7/23/2025
/ Antitrust Provisions ,
Appeals ,
Competition ,
Generic Drugs ,
Injunctive Relief ,
Litigation Strategies ,
Patent Litigation ,
Pharmaceutical Industry ,
Preliminary Injunctions ,
Regulatory Requirements ,
Reversal ,
Trade Dress
On February 14, 2025, the US Department of Education’s Office for Civil Rights (OCR) issued a Dear Colleague Letter about legal obligations for educational institutions under Title VI of the Civil Rights Act of 1964 and the...more
2/20/2025
/ Civil Rights Act ,
Colleges ,
Department of Education ,
Diversity and Inclusion Standards (D&I) ,
Equal Protection ,
First Amendment ,
OCR ,
Race Discrimination ,
SCOTUS ,
Students for Fair Admissions v Harvard College ,
Title VI ,
Trump Administration ,
Universities
As anticipated, the second Trump Administration began with the release of numerous executive orders. In this client alert, part of Jenner & Block’s “First 100 Days” series, we unpack three orders that target diversity,...more
1/24/2025
/ Affirmative Action ,
Civil Rights Act ,
Department of Justice (DOJ) ,
Department of Labor (DOL) ,
Diversity and Inclusion Standards (D&I) ,
Equal Employment Opportunity Commission (EEOC) ,
Executive Orders ,
Federal Contractors ,
Legislative Agendas ,
New Legislation ,
OFCCP ,
Title IX ,
Trump Administration ,
Universities